Storage after reconstitution, and the evidence behind the numbers
Sharps disposal is a legal obligation in most jurisdictions and a safety obligation everywhere. Household waste is not a route.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 21 of 34 of this archive, newest first.
Sharps disposal is a legal obligation in most jurisdictions and a safety obligation everywhere. Household waste is not a route.
The route did not close because of a rule about peptides.
Reported from the sessions, and from the two hours afterwards.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
A reminder that a purity figure is the output of a method, and that methods differ.
The header identifies the batch, the table records the tests, and the footer says who is answerable. Two of the three are usually incomplete.
The instrument determines the answer more than the drug does, and the trade quotes the answer without naming the instrument.
The route did not close because of a rule about peptides.
The observation that closes a facility is rarely the dramatic one.
Efficacy was never the question in this appraisal. Duration of treatment was.
Follow the resin, not the catalogue.
A dual agonist is one molecule with two receptor activities. A co-formulation is two molecules in one pen. The coverage treats them as synonyms.
What the Journal asks when a document arrives unsigned, and what the answers have been.
Reported from the sessions, and from the two hours afterwards.
Efficacy was never the question in this appraisal. Duration of treatment was.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
One randomised trial has combined a GLP-1 receptor agonist with supervised exercise. Its result is the single most useful piece of evidence in this area.
The argument for a baseline panel is that it makes every subsequent result interpretable. The argument against frequent monitoring is that noise accumulates faster than…
Somebody has to be answerable for a release document. On most certificates in this market, nobody is named at all.
Efficacy was never the question in this appraisal. Duration of treatment was.
Reported from the sessions, and from the two hours afterwards.
The route did not close because of a rule about peptides.
The evidence base is thin and the document says so, which is to its credit.
Three randomised withdrawal designs have tested what happens when treatment stops. Their results are consistent and they are consistently misreported.
The report states the gradient, the wavelength and the integration threshold, which is more than most.
A proper account of an operation that existed, and of what closing it cost.
The document is four pages. Three of them are about dates.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
We asked all four services what they can determine, on what timescale, at what price, and under what accreditation. The answers are printed in full.
The older-adult diet-and-exercise trials are the closest analogue to rapid pharmacological weight loss, and they are twenty years old.